Competing interests
Thrombosis
HEMOPHILIA, RTI, THROMBOSIS, RARE DISEASE
KSY was an employee of Takeda Development Center Americas, Inc. and stockholder of Takeda Pharmaceuticals Company Limited at the time of the analysis (current affiliation is Alexion Pharmaceuticals, Inc., AstraZeneca Rare Disease, Boston, MA, USA). CC, ED, DM, and CB are employees of RTI Health Solutions, and conducted contracted research for Takeda Pharmaceuticals Company Limited. WGK has received consulting fees from Homology Medicines, Indiana Hemophilia and Thrombosis Center, and Takeda Pharmaceuticals Company Limited.